Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.
Indoleamine 2,3-dioxygenase (IDO) is a tryptophan-degrading enzyme known to suppress antitumor CD8(+) T cells (TCD8). The role of IDO in regulation of antiviral TCD8 responses is far less clear. In addition, whether IDO controls both immunodominant and subdominant TCD8 is not fully understood. This...
Saved in:
| Main Authors: | Mateusz Rytelewski, Courtney E Meilleur, Maryam Atef Yekta, Peter A Szabo, Nitan Garg, Todd D Schell, Anthony M Jevnikar, Shayan Sharif, Bhagirath Singh, S M Mansour Haeryfar |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0090439&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)
by: Chiara Suvieri, et al.
Published: (2024-11-01) -
Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
by: Cemil Bilir, M.D., et al.
Published: (2017-07-01) -
Correlation of Indoleamine-2,3-Dioxygenase and Chronic Kidney Disease: A Pilot Study
by: Binbin Pan, et al.
Published: (2021-01-01) -
Electrochemical Analysis and Inhibition Assay of Immune-Modulating Enzyme, Indoleamine 2,3-Dioxygenase
by: Yasuhiro Mie, et al.
Published: (2025-02-01) -
Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus
by: Bonnie Reinhart, et al.
Published: (2012-01-01)